LGVN · Healthcare · $8M
$2.72+3.42%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Among 326 Biotechnology peers
Quarterly Revenue Growth
“이번 분기의 핵심 변화는 실적보다 HLHS 심장질환 임상 결과가 한 달 안팎으로 가까워졌다는 점이에요.”
In the company's words · 2026 2분기 earnings call